Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

131.58
Delayed Data
As of 10:06am ET
 +1.69 / +1.30%
Today’s Change
109.12
Today|||52-Week Range
162.00
+7.54%
Year-to-Date

Today’s Trading

Previous close129.89
Today’s open129.88
Day’s range129.36 - 131.91
Volume232,681
Average volume (3 months)2,868,270
Market cap$29.2B
Dividend yield--
Data as of 10:06am ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)+162.69%
Earnings growth (this year)--
Earnings growth (next 5 years)+21.40%
Revenue growth (last year)+24.05%
P/E ratio79.7
Price/Sales9.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...-0.02-0.04%
ZTSZoetis Inc-0.10-0.19%
INCYIncyte Corp+0.27+0.22%
MYLMylan NV-0.12-0.28%
Data as of 10:21am ET, 02/22/2017

Financials

Last reporting dateFebruary 16, 2017
EPS forecast (this quarter)$1.25
Annual revenue (last year)$3.1B
Annual profit (last year)$399.0M
Net profit margin12.94%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David Richard Brennan
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts


Search for Jobs